Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Goserelin

Known as: 6-[O-(1,1-Dimethylethyl)-D-serine]-10-deglycinamide Luteinizing Hormone-Releasing Factor (Pig) 2-(aminocarbonyl)hydrazide, Goserelin [Chemical/Ingredient], Luteinizing hormone-releasing factor (pig), 6-(O-(1,1-dimethylethyl)-D-serine)-10-deglycinamide-, 2-(aminocarbonyl)hydrazide 
A synthetic decapeptide analog of luteinizing hormone-releasing hormone (LHRH) with antineoplastic activity. Goserelin binds to and activates… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
To the Editor: In the PALOMA3 study, Turner et al. (July 16 issue)1 report that the addition of palbociclib to fulvestrant… Expand
Highly Cited
2015
Highly Cited
2015
ABSTRACTPremature ovarian failure is a devastating long-term toxic effect of chemotherapy for premenopausal women. The survival… Expand
Highly Cited
2005
Highly Cited
2005
PURPOSE Radiation Therapy Oncology Group protocol 85-31 was designed to evaluate the effectiveness of adjuvant androgen… Expand
Highly Cited
2004
Highly Cited
2004
The androgen-signaling pathway is critical to the development and progression of prostate cancer and androgen ablation is a… Expand
Highly Cited
2002
Highly Cited
2002
PURPOSE Current adjuvant therapies have improved survival for premenopausal patients with breast cancer but may have short-term… Expand
Highly Cited
2002
Highly Cited
2002
BACKGROUND We did a randomised phase III trial comparing external irradiation alone and external irradiation combined with an… Expand
Highly Cited
2002
Highly Cited
2002
PURPOSE Effective adjuvant treatment modalities in premenopausal breast cancer patients today include chemotherapy, ovariectomy… Expand
Highly Cited
2001
Highly Cited
2001
PURPOSE To test the hypothesis that androgen ablation before and during radiotherapy for locally advanced carcinoma of the… Expand
Highly Cited
1999
Highly Cited
1999
BACKGROUND Because the optimal timing of the institution of antiandrogen therapy for prostate cancer is controversial, we… Expand
Highly Cited
1997
Highly Cited
1997
BACKGROUND We conducted a randomized, prospective trial comparing external irradiation with external irradiation plus goserelin… Expand
  • table 3
  • figure 1
  • figure 2
  • table 4